JYOTHYLABNSEJyothy Labs Limited· Personal CareMinimalNeutral
Announced Wed, 13 Aug · 18:38 IST

Jyothy Labs Limited has informed the Exchange about General Updates

JYOTHYLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Jyothy Labs has published its unaudited consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26) in Business Standard (English) and Navshakti (Marathi). Total income from operations fell to ₹2,200.94 million from ₹2,630.39 million in the same quarter last year, a decline of about 16%. Profit before tax dropped sharply to ₹105.11 million from ₹213.12 million, while profit after tax nearly halved to ₹59.98 million from ₹142.37 million. Basic EPS declined to ₹3.19 from ₹7.58 year-on-year. However, total comprehensive income rose to ₹140.02 million from ₹119.02 million, helped by other comprehensive income. The results were approved by the Board on August 11, 2025 after a limited review by the statutory auditor.

Likely market impact

The sharp year-on-year decline in both revenue and bottom-line profit is a negative signal and may weigh on the stock in the near term. Investors will likely focus on whether this weakness is a one-off or part of a broader slowdown in demand for Jyothy Labs' product portfolio.